Schellhammer PF - Search Results

1

Hemibody irradiation in advanced prostatic carcinoma.

Kuban DA, Schellhammer PF, el-Mahdi AM. Kuban DA, et al. Among authors: schellhammer pf. Urol Clin North Am. 1991 Feb;18(1):131-7. Urol Clin North Am. 1991. PMID: 1704159

2

Prostate specific antigen levels after definitive irradiation for carcinoma of the prostate.

Schellhammer PF, Schlossberg SM, el-Mahdi AM, Wright GL, Brassil DN. Schellhammer PF, et al. J Urol. 1991 May;145(5):1008-10; discussion 1010-1. doi: 10.1016/s0022-5347(17)38514-2. J Urol. 1991. PMID: 1707987

3

Local failure after definitive radiation or surgical therapy for carcinoma of the prostate and options for prevention and therapy.

Schellhammer PF, Kuban DA, el-Mahdi AM. Schellhammer PF, et al. Urol Clin North Am. 1991 Aug;18(3):485-99. Urol Clin North Am. 1991. PMID: 1877111 Review.

4

Local failure and related complications after definitive treatment of carcinoma of the prostate by irradiation or surgery.

Schellhammer PF, el-Mahdi AM. Schellhammer PF, et al. Urol Clin North Am. 1990 Nov;17(4):835-51. Urol Clin North Am. 1990. PMID: 2219581 Review.

5

Local failure and related complications after definitive treatment of clinical stage C carcinoma of the prostate by irradiation or surgery.

Schellhammer PF, el-Mahdi AM, Kuban DA. Schellhammer PF, et al. Semin Urol. 1990 Nov;8(4):232-46. Semin Urol. 1990. PMID: 2284530 No abstract available.

6

Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate.

Kuban DA, Delbridge T, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Among authors: schellhammer pf. J Urol. 1989 Mar;141(3):572-4. doi: 10.1016/s0022-5347(17)40897-4. J Urol. 1989. PMID: 2465419

7

I-125 interstitial implantation for prostate cancer. What have we learned 10 years later?

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Among authors: schellhammer pf. Cancer. 1989 Jun 15;63(12):2415-20. doi: 10.1002/1097-0142(19890615)63:12<2415::aid-cncr2820631207>3.0.co;2-u. Cancer. 1989. PMID: 2720587

8

Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Among authors: schellhammer pf. Cancer. 1989 Jun 15;63(12):2421-5. doi: 10.1002/1097-0142(19890615)63:12<2421::aid-cncr2820631208>3.0.co;2-1. Cancer. 1989. PMID: 2720588

9

Mortality in prostatic carcinoma.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Among authors: schellhammer pf. Urology. 1989 Jan;33(1):1-5. doi: 10.1016/0090-4295(89)90055-1. Urology. 1989. PMID: 2911922

10

Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Among authors: schellhammer pf. Urology. 1987 Nov;30(5):420-6. doi: 10.1016/0090-4295(87)90372-4. Urology. 1987. PMID: 3118547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters